Denosumab Race Heats Up In Europe With Eight More Nods

Four More Sponsors Receive Pairs Of Positive Opinions From EMA’s CHMP

 
• By Dave Wallace
  
Eight denosumab biosimilars from four applicants received CHMP nods in April (Shutterstock)

More from Biosimilars

More from Business